President establishes commission to review federal response to opioid crisis
President Trump yesterday issued an executive order establishing a commission to study the scope and effectiveness of the federal response to drug addiction and the opioid crisis, and make recommendations to him for improving the response. The executive order calls for the commission to submit interim recommendations within 90 days and final recommendations by Oct. 1, unless the chair requests an extension. The commission will be administered by the Office of National Drug Control Policy, and its members and chair appointed by President Trump.
Related News Articles
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…